This year, people on Medicare Part D will not have to pay more than $2,000 in out-of-pocket drug expenditures — and that ...

SaveHealth reports on the third-party companies that work to negotiate discounts with pharmacies and pharmacy benefit ...

Commentary: New York must take on Big Pharma by demanding more transparency in pricing and ensuring generics aren't delayed ...

The decision could throw cold water on potential copycat suits seeking to hold large, self-funded employers responsible if ...

Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic drug supplies.

For small business owners like me, increasing costs threaten the well-being of our staff and the financial stability of our ...

Prescription ... drug pricing strategies lack transparency, with many companies raising prices on existing medications without any corresponding increase in R&D costs. In early 2025 alone, over ...